Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 7579444
Polymer-factor IX moiety conjugates
granted -
US 7579333
Therapy using a combination of raloxifene and alendronate
granted -
US 7579188
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
granted -
US 7579173
Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same
granted -
US 7579006
Method of treating immune pathologies with low dose estrogen
granted -
US 7579014
Mesoporous compositions for use in drug delivery
granted -
US 7579357
Dipeptidyl peptidase inhibitors
granted -
US 7579319
Methods for improving the structure and function of arterioles
granted -
US 7578998
Chimeric cytokine of IL-7 and beta-chain of HGF and methods of use
granted -
US 7575873
Reagents for diagnosing, imaging and treating atherosclerotic disease
granted -
US 7576076
Modified pyrimidine glucocorticoid receptor modulators
granted -
US 7575742
Method of treating autoimmune diseases with interferon-beta and IL-2R antagonist
granted -
US 7576050
GLP-1 exendin-4 peptide analogs and uses thereof
granted -
US 7576078
Tetrahydroquinoline analogues as muscarinic agonists
granted -
US 7576194
UspA2 nucleic acid of moraxella catarrhalis
granted -
US 7576175
Alpha-4 beta-1 integrin ligands for imaging and therapy
granted -
US 7576100
Muscarinic agonists
granted -
US 7576130
Dihydroxyl compounds and compositions for cholesterol management and related uses
granted -
US 7576065
Enhancing neurotrophin-induced neurogenesis by endogenous neural progenitor cells by concurrent overexpression of brain derived neurotrophic factor and an inhibitor of a pro-gliogenic bone morphogenetic protein
granted -
US 7576053
Methods and compositions for treating degenerative bone disorders
granted -
US 7575904
Polymer grafting by polysaccharide synthases
granted -
EP 2086964
BENZOYLAMINOHETEROCYCLYLVERBINDUNGEN, DIE SICH FÜR DIE BEHANDLUNG EINER DURCH GLK VERMITTELTEN KRANKHEIT EIGNEN
granted -
US 7572764
Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds
granted -
US 7572449
Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pestis F1-antigen and the other one for Yersinia pestis V-antigen
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.